Bryan Williams

Professor Bryan Williams is an Adjunct Professor at Monash University’s Department of Molecular and Translational Science and an Emeritus Director/Distinguished Scientist at the Hudson Institute of Medical Research. His research focuses on innate immunity, cancer biology, and antiviral mechanisms of interferons. He holds leadership roles in multiple organizations, including chairing BioGrid Australia and serving on scientific advisory boards globally. Williams has received numerous awards, including the Milstein Award and Fellowships from prestigious academies.

Education:

• PhD in Microbiology, University of Otago, New Zealand
• Postdoctoral training at National Institute for Medical Research, UK

Research Interests: Williams’ work centers on antiviral mechanisms, innate immune pathways, and cancer therapies. His discoveries in the 2-5A-RNaseL pathway and protein kinase R have advanced therapeutic strategies. Current research emphasizes translational applications in cancer and immune-related diseases.

Recent Contributions: His articles highlight innovative approaches in cancer cell profiling, immune response modulation via vaccines, and regulatory mechanisms in colitis and tumors. These studies bridge basic science and clinical translation.

Awards & Grants: Over 300 research outputs and 29 projects since 2006, including leadership in pediatric precision medicine and cytokine signaling studies. His grants include funding from the NHMRC and industry collaborations.

Leadership & Outreach: Chair of ICIS Award Committee, member of Australian Living Organoid Alliance, and editor for Journal of Virology. Engages in global science policy and industry advisory roles.